# Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery

> **NCT01181141** · PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 92 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** DU-176b (edoxaban)
- **DRUG:** Enoxaparin sodium 20mg

## Key facts

- **NCT ID:** NCT01181141
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-08
- **Final completion:** 2010-02
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2019-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181141, "Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01181141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*